Seguir
Sebastian Schneeweiss, M.D., Sc.D.
Sebastian Schneeweiss, M.D., Sc.D.
Professor of Medicine and Epidemiology, Harvard Medical School
Dirección de correo verificada de post.harvard.edu - Página principal
Título
Citado por
Citado por
Año
Variable selection for propensity score models
MA Brookhart, S Schneeweiss, KJ Rothman, RJ Glynn, J Avorn, T Stürmer
American journal of epidemiology 163 (12), 1149-1156, 2006
21682006
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss, J Avorn
Journal of clinical epidemiology 58 (4), 323-337, 2005
13072005
Risk of death in elderly users of conventional vs. atypical antipsychotic medications
PS Wang, S Schneeweiss, J Avorn, MA Fischer, H Mogun, DH Solomon, ...
New England Journal of Medicine 353 (22), 2335-2341, 2005
11682005
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data
S Schneeweiss, JA Rassen, RJ Glynn, J Avorn, H Mogun, MA Brookhart
Epidemiology (Cambridge, Mass.) 20 (4), 512, 2009
10112009
A combined comorbidity score predicted mortality in elderly patients better than existing scores
JJ Gagne, RJ Glynn, J Avorn, R Levin, S Schneeweiss
Journal of clinical epidemiology 64 (7), 749-759, 2011
7772011
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with …
T Stürmer, M Joshi, RJ Glynn, J Avorn, KJ Rothman, S Schneeweiss
Journal of clinical epidemiology 59 (5), 437. e1-437. e24, 2006
7712006
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data
S Schneeweiss, JD Seeger, M Maclure, PS Wang, J Avorn, RJ Glynn
American journal of epidemiology 154 (9), 854-864, 2001
7662001
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
S Schneeweiss
Pharmacoepidemiology and drug safety 15 (5), 291-303, 2006
6982006
Full coverage for preventive medications after myocardial infarction
NK Choudhry, J Avorn, RJ Glynn, EM Antman, S Schneeweiss, ...
New England Journal of Medicine 365 (22), 2088-2097, 2011
6482011
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
DH Solomon, S Schneeweiss, RJ Glynn, Y Kiyota, R Levin, H Mogun, ...
Circulation 109 (17), 2068-2073, 2004
6462004
Indications for propensity scores and review of their use in pharmacoepidemiology
RJ Glynn, S Schneeweiss, T Stürmer
Basic & clinical pharmacology & toxicology 98 (3), 253-259, 2006
6032006
Repeated hospitalizations predict mortality in the community population with heart failure
S Setoguchi, LW Stevenson, S Schneeweiss
American heart journal 154 (2), 260-266, 2007
5882007
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records
Y Kiyota, S Schneeweiss, RJ Glynn, CC Cannuscio, J Avorn, DH Solomon
American heart journal 148 (1), 99-104, 2004
5522004
Patterns of cardiovascular risk in rheumatoid arthritis
DH Solomon, NJ Goodson, JN Katz, ME Weinblatt, J Avorn, S Setoguchi, ...
Annals of the rheumatic diseases 65 (12), 1608-1612, 2006
5192006
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
S Schneeweiss, S Setoguchi, A Brookhart, C Dormuth, PS Wang
Cmaj 176 (5), 627-632, 2007
4882007
Incidence and predictors for chronicity of headache in patients with episodic migraine
Z Katsarava, S Schneeweiss, T Kurth, U Kroener, G Fritsche, A Eikermann, ...
Neurology 62 (5), 788-790, 2004
4882004
The comparative safety of analgesics in older adults with arthritis
DH Solomon, JA Rassen, RJ Glynn, J Lee, R Levin, S Schneeweiss
Archives of internal medicine 170 (22), 1968-1978, 2010
4872010
Use of comorbidity scores for control of confounding in studies using administrative databases
S Schneeweiss, M Maclure
International journal of epidemiology 29 (5), 891-898, 2000
4692000
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis
DH Solomon, E Massarotti, R Garg, J Liu, C Canning, S Schneeweiss
Jama 305 (24), 2525-2531, 2011
4322011
Good practices for real‐world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in …
ML Berger, H Sox, RJ Willke, DL Brixner, HG Eichler, W Goettsch, ...
Value in Health 20 (8), 1003-1008, 2017
4192017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20